Back
Day Range
$31.72
$34.16
52-Week Range
$31.71
$90.32
Volume
951,302
50D / 200D Avg
$39.76
/
$59.33
Prev Close
$33.22
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 81.6 | 0.4 |
| P/B | 3.8 | 2.9 |
| ROE % | 6.0 | 3.8 |
| Net Margin % | 11.0 | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
Hold
$101.20
+219.0%
Low: $60.00
High: $125.00
Forward P/E
8.2
Forward EPS
$3.89
EPS Growth (est.)
+0.0%
Est. Revenue
470 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$16.04
$14.31 – $18.79
|
1.6 B | 5 |
| FY2029 |
$12.81
$11.43 – $15.01
|
1.4 B | 2 |
| FY2028 |
$9.18
$4.72 – $13.23
|
1 B | 7 |
Key Takeaways
Debt/Equity of 0.01 — conservative balance sheet
Generating 46.73M in free cash flow
P/E of 81.55 — premium valuation
Cash machine — converts 223.67% of earnings into free cash flow
Capital efficient — spends only 0.04% of revenue on capex
ROIC of 2.48% — low return on invested capital
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
6.01%
ROIC2.48%
Net Margin10.97%
Op. Margin7.85%
Safety
Debt / Equity
0.01
Current Ratio5.80
Interest Coverage2.73
Valuation
P/E Ratio
81.55
P/B Ratio3.78
EV/EBITDA109.45
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 190.41M | Net Income (TTM) | 20.89M |
| ROE | 6.01% | ROA | 3.71% |
| Gross Margin | 98.58% | Operating Margin | 7.85% |
| Net Margin | 10.97% | Free Cash Flow (TTM) | 46.73M |
| ROIC | 2.48% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.01 | Current Ratio | 5.80 |
| Interest Coverage | 2.73 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 81.55 | P/B Ratio | 3.78 |
| P/S Ratio | 8.95 | PEG Ratio | -1.08 |
| EV/EBITDA | 109.45 | Dividend Yield | 0.00% |
| Market Cap | 1.70B | Enterprise Value | 1.64B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 190.41M | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | 20.89M | -175.85M | -38.99M | -24.07M | -30.91M |
| EPS (Diluted) | 0.39 | -4.38 | -2.36 | -2.87 | -5.81 |
| Gross Profit | 187.71M | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | 14.95M | -187.67M | -41.38M | -24.40M | -31.53M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 563.83M | 330.97M | 180.69M | 26.50M | 35.55M |
| Total Liabilities | 113.72M | 85.86M | 23.18M | 16.15M | 17.76M |
| Shareholders' Equity | 450.12M | 245.11M | 157.51M | 10.35M | 17.79M |
| Total Debt | 2.69M | 52.83M | 403,000.0 | 155,000.0 | 457,000.0 |
| Cash & Equivalents | 70.11M | 87.93M | 169.68M | 14.60M | 21.30M |
| Current Assets | 355.81M | 293.89M | 171.36M | 15.65M | 22.42M |
| Current Liabilities | 61.36M | 18.75M | 11.51M | 7.31M | 8.01M |